Jackie joined SV Health Investors in 2017 as a Senior Associate and brings nine years of science, research and business development experience.
Jackie worked at Genentech in the Business Development Group, where she was primarily responsible for partnering activities in Neuroscience. Her transaction experience includes sourcing opportunities, leading due diligence teams and negotiating contract terms to access new therapies and technologies. Her transactions span the full spectrum of deal structures and therapeutic areas, including technology and platform in-licenses, product out-licenses and research collaborations. She is a scientist by training; her dissertation focused on investigating the role of amyloid-beta in autoimmunity and neurodegeneration, for which she received the Ruth L. Kirschstein National Research Service Award from the NIH.
BS, Biology and Chemistry, Boston College; PhD in Neuroscience, Stanford School of Medicine (Steinman Laboratory); MBA, Stanford Graduate School of Business.
Outside of SV
Jackie enjoys writing about scientific content to engage a broader public audience in science through her personal blog and speaking forums, including her LOWkeynotes talk while at Stanford.